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Clonidine, but not bradykinin or ANP, inhibits Na and water trans-
port in DahI SS rat CCD. We examined the actions of potentially
natriuretic autacoids in the isolated perfused cortical collecting duct
(CCD) dissected from inbred DahI (Rapp strain) salt-sensitive rats (SS).
Atrial natriuretic peptide (ANP, 10 nM), bradykinin (BK, 10 nM), and
clonidine (1 .tM) were studied to determine their effects on the lumen-
to-bath flux of 22Na (JIb, pmol min mm'), hydraulic conductivity
(Pr, /.Lnh/s), and transepithelial voltage (VT, mY). ANP and BK have
been shown by others to significantly reduce net Na reabsorption and
hydraulic conductivity in the Sprague-Dawley (SD) rat CCD, but
previous results from our laboratory showed no ANP or BK effect in
the SD CCD. In the present study, we were also unable to observe any
effect of either ANP or BK in the SS rat CCD. However, in the
presence of AVP, clonidine (a partial a2-adrenergic receptor agonist)
significantly reduced Ib and P1 from 139 6 (sEM) to 88 7 and from
959 176 to 490 73, respectively. In addition, clonidine significantly
depolarized VT from —14.5 2.8 to —11.2 1.8. However, unlike its
effects in the SD rat CCD, yohimbine (300 nM, an a2-adrenergic
receptor antagonist) did not significantly reverse the effects of clonidine
JJ—b P1. or VT in the SS rat CCD.
The kidney of the Dahi salt-sensitive rat (SS) exhibits a
blunted pressure natriuretic response when compared to the
kidney of the DahI salt-resistant rat (SR) both in vitro [1] and in
vivo [2]. While the mechanism for this defect in the natriuretic
response is unknown, the difference between the SS and SR
kidneys may involve a dysfunction in the regulation of Na
reabsorption by one or more segments of the nephron. Recent
reports indicate that the thick ascending limb of the loop of
Henle may be one site at which the SS nephron shows increased
Na reabsorption in comparison with the SR [3—5]. Kirchner [4]
has shown that SS and SR rats maintained on a high salt (8%)
diet had equal rates of Na excretion and C1 reabsorption by
the 1oop of Henle. The renal arterial blood pressure in the SS
rats, however, was elevated compared to the SR rats. When the
perfusion pressure in the SS rats was decreased to the same
level as the SR rats by clamping the aorta cranial to the renal
arteries, the rate of Cl— reabsorption in the loop segment
increased. These findings were interpreted to indicate that, at
equal renal perfusion pressures, the thick ascending limb reab-
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sorbed NaCI more rapidly in the SS than in the SR rat, although
the author also noted that changes in reabsorption by other
segments could not be ruled out by these data. Kirchner has
also found that the increased loop chloride reabsorption in the
SS rat is observed even before the development of hypertension
[5].
Mechanisms that regulate Na reabsorption may also differ
between cortical collecting ducts (CCDs) of SS and SR rats. For
example, we have observed that both lumen-to-bath (JJb) and
bath-to-lumen (J1) unidirectional 22Na fluxes are lower in
CCDs from SR rats, than in those from SS or Sprague-Dawley
(SD) rats [6, 7]. Regulatory autacoids may also have differing
effects on the CCD in the two strains. Among such autacoids,
a2-adrenergic receptor agonists have been shown to increase
Na and water excretion [8]. In perfused rabbit CCDs, Kroth-
apalli and Suki [9] showed that a2-adrenergic receptor activa-
tion inhibits the AVP-induced osmotic water permeability (Pf),
and in the SD rat CCD, we have shown that clonidine, a partial
a2-agonist, inhibits I.b and P [10]. In isolated segments of
rabbit collecting ducts s2-adrenergic agonists inhibit the AVP-
induced cAMP accumulation [11—13]. This inhibition of cAMP
production, which would also lead to inhibition of P1 in the
presence of AVP, occurs through the activation of a pertussis
toxin-sensitive mechanism, presumably the inhibitory guanine
nucleotide binding protein, G1 [14, 15].
In addition to a2-adrenergic agonists, atrial natriuretic pep-
tide (ANP) and bradykinin (BK) have also been shown to
augment water and Na excretion by the kidney [16—18], and
part of that action has been attributed to effects in the collecting
duct. Zeidel et a! [191 and Nonoguchi et al [20] have demon-
strated a direct action of ANP on Na reabsorption by collect-
ing duct cells. However, Brier et al [21] have found that
perfused kidneys isolated from Dahi SS rats have an impaired
natriuretic response to pharmacological doses of ANP.
Tomita et al [22, 23] and Nonoguchi et al [20] also reported
that both ANP and BK inhibited net Na and C1 reabsorption
without an associated change in the transepithelial voltage in
isolated perfused CCDs from Sprague-Dawley (SD) rats. They
concluded that approximately one-half of the net Na absorp-
tion in this nephron segment occurs through an electrically
silent, thiazide-inhibitable, cotransporter that is inhibited
through the actions of ANP and BK [20, 22—24]. However, in
our laboratory Rouch et al [25] found no effect of BK, ANP, or
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hydrochlorothiazide (HCTZ) on either lb' or on any electro-
physiological parameters of principal cells in CCDs from SD
rats. Among the possible reasons for the differences between
our results and the previously cited ones of Knepper and his
coworkers [20, 22—24], is the fact that their rats were maintained
on a low Na diet whereas ours were not. (See Rouch et a! [25]
for a complete discussion of the possible reasons for differences
in the results of these two laboratories.) Thus, the lower Na
diet in the studies from Knepper' s laboratory would have been
expected to result in a lower Na delivery to the CCD.
Because the SS rat is reported to have increased salt reab-
sorption in more proximal nephron segments that also results in
a decrease in salt delivery to the CCD [4, 5], we hypothesized
that the SS rat CCD might express a thiazide-sensitive trans-
porter that could be inhibited by ANP, BK, or other autacoids,
and thus increase salt excretion. Therefore, we studied the
effects of ANP, BK, and clonidine in the isolated perfused CCD
from SS rats, and compared these data with data derived from
the parent SD stock. We found that ANP and BK failed to
produce any inhibition of Na or water absorption by the SS rat
CCD, which is similar to results previously reported for the SD
rat CCD [25]. Clonidine was able to partially inhibit both Na
and water absorption in the SS rat CCD, which is again similar
to data previously reported for the SD rat CCD [10]. However,
unlike the effect seen in the SD rat CCD, the a2-adrenergic
antagonist yohimbine was unable to reverse significantly the
inhibitory effects of clonidine on Ib' P, and VT in the SS rat
CCD.
Methods
Male inbred Dahl salt-sensitive (SS) rats weighing 35 to 50 g
upon arrival were used in this study. The rats were obtained
from barrier-maintained, pathogen-free colonies at Harlan
Sprague Dawley Inc. (Indianapolis, Indiana, USA). The rats
were shipped to our Animal Resources facility in filtered
cartons and when received were maintained in a barrier room
with a standard pelleted diet (Prolab RMH 1000; Agway) and
tap water ad libitum. This diet contains approximately 170 to
180 meq/kg feed of both Na and Kt With the exception of one
set of experiments, all of the rats were treated with either a
single 2.5 or 5 mg intramuscular depot injection of deoxycorti-
costerone pivalate (DOC) two to four days after receipt, and
were used four to nine days after injection (rats weighed 80 to
110 g on the day of use). These pharmacological doses of DOC,
in the presence of AVP, lead to maximal stimulation of Na
absorption by the CCD [26—28]. The 5 tug dose duplicates that
given to SD and SS rats described in previously published
studies from our laboratory [26—28]. We have since begun
injections of 2.5 mg DOC (a lower but still pharmacological
dose) and found no significant difference in control levels of
I—b, VT, or P in the presence or absence of AVP when
compared to those injected with the 5 mg dose (unpublished
observations).
In spite of the administration of DOC in the presence of a
normal diet, the rats were expected to be normotensive at the
time of study. In unpublished experiments in Dahi SS rats,
which had received 5 mg of DOC pivalate eight days previously,
an indwelling catheter was placed in the femoral artery under
ether anesthesia for the measurement of conscious blood pres-
sures over a period of two to five days following surgery. In six
such animals, the average mean arterial pressure was 110.3
2.8 mm Hg. There was no significant increase in blood pressure
over this period of time in any of the animals. These blood
pressures are the same as those previously reported for SS, SD
and SR rats of the same age after maintenance for 14 days on a
0.3% NaCI diet [29], and the same as those reported for older
(300 g) rats of all three strains while on a 0.4% NaCI diet [30].
Rats used for the transport experiments were killed by
decapitation. Both kidneys were immediately removed, the
capsules were stripped off and five or six coronal slices were cut
from each kidney. The slices were placed in a chilled (15 to
20°C) bathing solution (described below) to which 6 g/dl of
purified bovine serum albumin had been added. Cortical col-
lecting ducts were dissected in the same chilled solution without
the aid of collagenase. The length of segments ranged from 0.28
to 0.82 mm when measured between the perfusion and collec-
tion pipettes and averaged 19.9 0.3 m in inside diameter.
The tubules were mounted and perfused as described previ-
ously [26, 27].
The perfusion experiments were carried out at 38°C, and
were designed so that measurements of lumen-to-bath 22Na
flux (JI—b), osmotic water permeability (Pf), and transepithelial
voltage (VT) could be performed in the same experiment. The
composition of the perfusion and bathing solutions simulated
the composition of tubular fluid normally entering the early
distal tubule and the renal interstitial fluid, respectively [31—33].
In particular, the perfusate had a lower pH (6.6), contained no
metabolic substrates, and was hypoosmotic to the bathing
solution, while the latter resembled an ultrafiltrate of rat
plasma. The perfusate contained in mM: 88 NaCl, 5 KC1, 2 Na
phosphate (pH 7.4), 1.5 CaCl2, 0.5 MgCI2, and 50 urea. The final
osmolality averaged 227.6 3.0 (SD) mOsm/kg H20, and the
pH was adjusted to 6.6. The bathing solution contained in mM:
122 NaC1, 25 NaHCO3, 5 KC1, 5 Na acetate, 2 Na phosphate
(pH 7.4), 1.5 CaCI2, 0.5 MgC12, 8 glucose, 4 L-alanine, and 6
urea. The final osmolality averaged 317.1 3.0 (SD) mOsm/kg
H20, and the pH was adjusted to 7.40.
Twenty-five to fifty JLCi of well-dialyzed [methoxy-3H]inulin
were added per ml of perfusate in order to determine the
perfusion rate from the rate of collection of the inulin. The
presence of inulin in the perfusate also enabled us to check for
the possible leakage of perfusate into the bathing solution. The
leakage rate was less than 1.0% of the rate of perfusion for all
experiments reported, and less than 0.5% in nearly all experi-
ments. Tubule segments were rapidly perfused at 10 to 15
ni/mm to ensure that the osmolality of the luminal fluid did not
increase by more than 40 mOsm/kg H20 at the highest rates of
osmotic water absorption. At these high flow rates, we do not
observe any changes in Ib' P, or VT with changes in
perfusion rate.
Measurement of volume absorption rate and osmotic water
permeability
The perfusion rate (V0, nI/mm) was calculated from the
appearance rate of [methoxy-3H]inulin delivered to the collec-
tion pipette. The collection rate (YL, nl/min) was calculated
from the volume collected (nI) as measured with a constant-
bore pipette (1.1 to 1.4 nI/mm), over a 10 minute collection
period. The volume absorption rate (J,, nl min' mm') was
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calculated as the difference between \Tand L normalized by
the perfused length of the tubule, L as described in detail
previously [26, 34]. Pf (.tm/s) was calculated from the observed
water flow and the measured osmolalities of the initial perfusion
and bathing solutions [26, 27].
Measurement of lumen-to-bath flux of Na
I-.b (pmol min mm') for Na was determined by adding
10 to 25 tCi/mI 22Na to the perfusate and measuring its rate of
appearance in the bathing solution. The bathing solution was
bubbled continuously with 95% 02/5% C02, and was isotope
free. In addition, the bathing solution was perfused through the
bath chamber at 0.3 mI/mm and was collected at the same rate
into scintillation vials by using a suction needle positioned in
the bath at the opposite end of the chamber from the solution
inflow. These collections were counted for 22Na and [methoxy-
3H]inulin. Inulin was present in order to determine the leakage
rate of perfusate to the bathing solution. The 22Na counts were
corrected for this rate of leakage. Ib was calculated as the
corrected 22Na counts divided by the product of the time over
which the bath collections were made, and the specific activity
of the 22Na in the perfusion solution. This calculated flux was
normalized by dividing by the tubule length [27].
Flux measurement protocols
Various protocols were used to study the effects of ANP,
BK, clonidine and yohimbine on I-.b' Pf and VT. The effects of
these compounds on the SD rat CCD have been previously
reported [10, 25]. After mounting the tubule between the
micropipettes, perfusion was begun and AVP (220 pM) was
added to the bath at various times depending on the specific
protocol. Once VT became stable (usually 15 to 30 mm), four to
five samples of the perfusate and bath were collected. After
various agents (ANP, BK, clonidine, and yohimbine) were
added to the bath either individually or in combination, four to
five samples were collected over a 40 to 50 minute period (see
Results for specific protocols). An equilibration period of at
least 20 minutes was employed following each bath exchange.
Measurement of transepithelial voltage during flux
experiments
In each experiment, transepithelial voltage (VT, mV, lumen
with respect to bath) was measured between calomel electrodes
connected to 0.9% NaC1-4% agar bridges inserted in the perfu-
sion pipette and bathing solutions using a high impedance
electrometer and a strip-chart recorder. Voltages presented in
the Results are those measured without correction for liquid
junction potentials because we were interested only in the
observed change with drug treatment.
Sources of biochemicals
Clonidine, yohimbine and AVP were obtained from Sigma
Chemical Co. (St. Louis, Missouri, USA). AVP was added to
the bathing solution, from a stock solution of 220 M in water,
to a final concentration of 220 prvi. Clonidine and yohimbine
were added to the bathing solution from stock solutions made
with deionized water. Deoxycorticosterone pivalate (Percorten)
was obtained from Ciba-Geigy Animal Health (Memphis, Ten-
nessee, USA). ANP (1-28) and BK were obtained from Penin-
Table 1. Response to AVP and BK in CCD from normal and DOC-
treated SS rats
Normal DOC-treated
Pf, jsm
Control —2 90 (5) 80 77 (4)
AVP (steady state) 874 296 (5) 1,102 152 (4)
AVP + BK 1,011 321 (5) 1,212 103 (4)
Jl—b, pmol min' mm'
Control 31 7 (4) 85 8 (4)"
AVP (steady state)
AVP + BK
73 15 (4)
75 15 (4)
186 19 (4)ad
191 20 (4)
VT, mY
Control —1,8 0.8 (5) —11.3 1.7 (4)"
AVP (steady state) —10.9 2,1 (5)a —24.2 4.0 (4)Ie
AVP + BK —11.6 2.2 (5) —21.6 5.2 (4)C
Values are means SE; number of tubules is in parentheses.
Abbreviations are: AVP, arginine vasopressin; DOC, deoxycorticoste-
tone pivalate; CCD, cortical collecting duct; Pf, water permeability;
.1!.,,, lumen-to-bath flux of Na; VT, transepithelial voltage, Signifi-
cantly different from control tubules by paired 1-test: °P < 0.002, "P <
0.02, C < 0.05. Significantly different from normal (non-DOC-treated
tubules) by unpaired 1-test: dp < 0.005; ep < 0.05.
sula Laboratories (Belmont, California, USA). Radiolabeled
compounds were obtained from Du Pont-New England Nuclear
Products (Boston, Massachusetts, USA).
Statistical analysis
Results are presented as means SE unless otherwise spec-
ified. Comparisons between different groups of animals (for
example, normal vs. DOC-treated) were made with the non-
paired t-test. In most experiments mean values between differ-
ent experimental periods were compared by analysis of vari-
ance with experiments treated as blocks, using the Scheffd
F-ratio test to determine significance. In some experiments
significant differences were determined by Tukey's multiple
comparisons procedure. Differences were considered signifi-
cant for P < 0.05.
Results
Effect of AVP and BK on /b' P, and VT
We studied the effect of AVP and the natriuretic peptide, BK,
on J,,,, P, and VT in normal and DOC-treated SS rat CCDs.
As summarized in Table 1, the increase in lb with AVP
addition in CCDs from DOC-treated rats (from 85 8 to 186
19 pmol min' mm') is greater than that in CCDs from rats not
treated with DOC (from 31 7 to 73 15 pmol min' mm').
Similar results are observed for the changes in VT. These data
confirm our previously reported synergism of action between
AVP and DOC to increase l—.b and to hyperpolarize VT in SS
rat CCDs [27]. Addition of 10 flM BK to the bath (Table 1) did
not alter the AVP-dependent Ib' Pf, or VT in either normal
or DOC-treated tubules. The perfusion rates in these experi-
ments averaged 13.4 nl min' with a coefficient of variation
(CV) between experiments of 7.8%, and the CV within exper-
iments of 11.0%.
Effect of ANP on J,,,, Pf, and VT
Data describing the effect of the addition of 10 nss ANP to the
bath on J,, P, and VT in CCDs from DOC-treated SS rats are
shown in Table 2 (10 flM ANP is 1,000 times the normal plasma
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DOC-treated
P, rm S
AVP (steady state) 1,201 246 (5)
AVP + ANP 1,176 193 (5)
JI—b, pmol mm - mm'
AVP (steady state) 136 11(5)
AVP + ANP 123 11(5)
VT, mV
AVP (steady state) -11.6 1.8 (5)
AVP + ANP —11.5 1.5 (5)
level found in SS rats [35]). ANP clearly has no statistically
significant effect on AVP-stimulated P, and VT. These
data are similar to data previously reported in the SD rat CCD
[25]. Because we did not observe any inhibitory effect of ANP
on I..b in maximally stimulated tubules (such as in the pres-
ence of AVP and DOC) we did not perform similar experiments
in non DOC-treated rat CCDs. The perfusion rates in these
experiments averaged 13.8 nI min with a CV between exper-
iments of 13.8%, and a CV within experiments of 9.2%.
Effect of clonidine on J1..,,, Pf, and VT
We examined the effect of the addition of 1 M clonidine to
the bath (Fig. 1) on P, and VT in CCDs from DOC-treated
SS rats. In the presence of clonidine, and P were signifi-
cantly reduced (from 139 6 to 88 7 pmol min' mm (P <
0.001), and from 959 176 to 490 73 gm/sec (P < 0.002),
respectively). Because Mon et al [36] found that the IC60 for
yohimbine (an a2-adrenergic receptor antagonist) was 181 nM
for human a2-adrenoceptors found in platelets bathed with 10
/.M epinephrine, we chose 300 nrvi yohimbine as a reasonable
concentration of yohimbine to use in order to block a2-adreno-
ceptor activation by clonidine. However, unlike the data pre-
viously reported by us in SD rat CCD [10], addition of 300 nM
yohimbine was ineffective in reversing the effect of 1 M
clonidine fully on I-.b and P (from 88 7 to 94 7 pmol min'
mm and from 490 73 to 641 112 tmIsec, respectively).
I—b and P returned toward control levels (to 107 12 pmol
mint mm', and to 895 73 .tm/sec, respectively) following
the removal of clonidine and yohimbine from the bath, indicat-
ing recovery. Clonidine also depolarized VT significantly from
—14.5 2.8 mV to —11.2 1.8 mV (P < 0.01), but was not
significantly reversed by yohimbine (—13.1 1.7 mV). VT
returned to control levels following the removal of clonidine
and yohimbine from the bath (to —16.2 3.6 mV). The
perfusion rates in these experiments averaged 13.4 nl min
with a CV between experiments of 6.8%, and a CV within
experiments of 10.3%.
Discussion
A primary objective of the present study was to determine
whether Na reabsorption in the SS rat CCD, which is exposed
to a decreased rate of Na delivery in vivo [3—5], is inhibited by
AVP AVP+ AVP+ AVP
Clon Clon +
ANP or BK, and to determine how the response compares with
that previously reported for the SD rat CCD [20, 22, 23, 25].
Our data (Tables 1 and 2) clearly show that neither ANP (in
DOC-treated SS rats) nor BK (in normal and DOC-treated SS
rats) have any inhibitory effect on Ib or P in the CCD. These
data stand in contrast to those of Nonoguchi et al [20] and
Tomita et al [22], who reported that approximately 50% of the
net Na flux was inhibited by either 10 nM ANP or 1 nM BK,
and that these autacoids acted without altering VT. Their data
[20, 23], as well as the observation that hydrocholorothiazide
(HCTZ) inhibited approximately 50% of the NaCl reabsorption
in the SD rat CCD [24], indicate the presence of an electroneu-
tral NaCl cotransporter in CCD principal cells, which operates
in parallel with the electrogenic Na channel, and which is
inhibited by ANP and BK. Although our present data contradict
these conclusions, they are compatible with those reported
previously for the SD rat CCD by our laboratory [25]. Thus, our
data indicate that all net Na transport in SD [28, 37] and SS
[27] rat CCDs occurs through the apical membrane Na chan-
nel. Additionally, we have also shown the absence of any
inhibitory effect of HCTZ in the SR rat CCD [6].
As discussed in detail by Rouch et al [25], there are several
possible reasons for the differences between our results and
those reported by Knepper's laboratory [20, 22—24]. First, the
perfusion rate used in our previous studies [25] and in these
Table 2. Lack of ANP reponse in AVP-stimulated, DOC-pretreated
SS rat CCDs
Values are means sE; number of tubules is in parentheses.
Abbreviations are: AVP, arginine vasopressin; DOC, deoxycorticoste-
rone pivalate; ANP, atrial natriuretic peptide; CCD, cortical collecting
duct; P1, water permeability; Jl-.b, lumen-to-bath flux of Nat; VT,
transepithelial voltage. ANP had no significant effect on Pf, or VT.
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Fig. 1. Effect of I xM clonidine (Clon) and 300 nM yohimbine (Yoh)
added to the bathing solution on 22Na lumen-to-bath flux (J,.b) and
water permeability (Pf) in A VP-stimulated cortical collecting ducts
(CCD5) from DOC-treated Dahl SS rats. Dashed lines, individual
experiments; solid line, mean SE.
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studies was 10 to 15 nI/mm as required for the accurate
measurement of I—.b However, the perfusion rate was <1
nI/mm in the studies of Knepper and his colleagues [20, 22—24]
in order to measure the net Na flux by chemical methods.
Furthermore, in order to approximate in vivo conditions [31—
33], the perfusate used in our studies had a lower pH and a
different composition than the bathing solution, whereas it was
the same as the bathing solution in the other studies. Finally,
the rats were maintained on a low Na diet in Knepper's
laboratory (M. A. Knepper, personal communication), whereas
they were kept on a normal (—1% NaC1) diet in our studies.
Thus, it is highly interesting that, unless the different results
relate to uncontrolled differences in the rat colonies, the thia-
zide-sensitive transporter, which is clearly demonstrated by the
experiments of Knepper and his collaborators [20, 22—24], may
be expressed either by a change in luminal fluid pH, composi-
tion, and/or flow rate, or possibly by a low Na diet in the SD
rat.
On the other hand, our results do show that clonidine
partially inhibits both jb and Pf in the SS rat CCD as it does
in the SD CCD. The effects of this partial a2 agonist are
interesting because it has been shown that the density of
a2-adrenergic receptors is greater in the CCD of the SS rat
compared to the SR rat even before the development of
hypertension in the SS rat [38]. a2-adrenoceptor activation is
known to depress cellular cAMP levels [11—13], to depress the
hydroosmotic action of AVP in the rabbit and rat CCD [9, 10],
and to inhibit the lumen-to-bath flux of 22Na in SD rat CCDs
[10]. Chen et al [10] reported that clonidine depressed Iband
Pf by about 30%, and depolarized VT. These effects of clonidine
were reversed by the a2-adrenergic receptor antagonist, yohim-
bine, implying that the natriuretic and diuretic effects of cloni-
dine were elicited through the activation of a2-adrenergic
receptors. Also, Rouch et al [25] were able to show that
clonidine reduced Ib in the SD CCD by inhibiting the
amiloride-sensitive conductance of the apical membrane.
As shown in Figure 1, 1 M clonidine reduced I—bandP by
approximately 35%, which is almost identical to the effect seen
in AVP+DOC-stimulated CCDs from the SD rat CCD [10].
However, unlike the effect seen in the SD rat CCD [10], 300 flM
yohimbine did not reverse the effect of 1 j.LM clonidine on either
J, or P in the SS rat CCD—although yohimbine produced a
limited reversal of '1b and P in most of the experiments, the
average effect was not statistically significant. The difference
between the effect of yohimbine in the SS and SD CCD may
relate simply to a variability in the time-dependence of the
transport parameters in the two groups of experiments, or to an
actual difference in the adrenoceptor involved in the clonidine
inhibition. Both pharmacological and cloning data have shown
that there are at least three a2-adrenoceptor subtypes in the rat,
and that, whereas two of the subtypes have a high yohimbine
affinity, the third does not [39, 40]. Given the complexities of
characterizing the functional effects of possibly multiple a2-
adrenoceptor subtypes in the CCD, it seems more prudent to
pursue the investigation of possible differences in receptor
subtypes among SD, SS and SR rat CCDs using biochemical
approaches. However, the present results suggest that the
exploration of such differences may be fruitful.
In summary, we found that neither ANP nor BK inhibited
I-.b' Por VT in the SS rat CCD. Thus, in spite of the expected
diminution of the Na load to the CCD in the prehypertensive
SS rat [4, 5], there appears to be no induction of the electrically
silent NaCl cotransporter that is inhibited by ANP or BK. On
the other hand, I M clonidine partially inhibited P and
VT in the SS rat CCD, although these effects were not reversed
significantly by yohimbine.
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